BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26316103)

  • 1. Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis.
    Wang W; Mou S; Wang L; Zhang M; Shao X; Fang W; Lu R; Qi C; Fan Z; Cao Q; Wang Q; Fang Y; Ni Z
    Sci Rep; 2015 Aug; 5():12644. PubMed ID: 26316103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
    Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
    J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus.
    Navarro-Quiroz E; Pacheco-Lugo L; Lorenzi H; Díaz-Olmos Y; Almendrales L; Rico E; Navarro R; España-Puccini P; Iglesias A; Egea E; Aroca G
    PLoS One; 2016; 11(11):e0166202. PubMed ID: 27835701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
    Navarro-Quiroz E; Pacheco-Lugo L; Navarro-Quiroz R; Lorenzi H; España-Puccini P; Díaz-Olmos Y; Almendrales L; Olave V; Gonzalez-Torres H; Diaz-Perez A; Dominguez A; Iglesias A; García R; Aroca-Martinez G
    PLoS One; 2017; 12(11):e0187973. PubMed ID: 29136041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling.
    Xu ZQ; Ding Y; Huang XY; Xiang W; He XJ
    Inflammation; 2021 Oct; 44(5):2106-2119. PubMed ID: 34091806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells.
    Han X; Wang Y; Zhang X; Qin Y; Qu B; Wu L; Ma J; Zhou Z; Qian J; Dai M; Tang Y; Chan EK; Harley JB; Zhou S; Shen N
    Arthritis Rheumatol; 2016 Sep; 68(9):2232-43. PubMed ID: 27111096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN.
    Ai K; Zhu X; Kang Y; Li H; Zhang L
    Exp Mol Pathol; 2020 Feb; 112():104358. PubMed ID: 31836508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network.
    Cheng C; Guo F; Yang H; Ma J; Li H; Yin L; Li M; Liu S
    Lupus; 2022 Dec; 31(14):1786-1799. PubMed ID: 36223498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of the lncRNA
    Zhang B; Zhao C; Hou L; Wu Y
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating exosomal microRNAs as biomarkers of lupus nephritis.
    Chen F; Shi B; Liu W; Gong J; Gao J; Sun Y; Yang P
    Front Immunol; 2023; 14():1326836. PubMed ID: 38223506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus.
    Kim BS; Jung JY; Jeon JY; Kim HA; Suh CH
    HLA; 2016 Oct; 88(4):187-93. PubMed ID: 27596248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA expression profiles associated with systemic lupus erythematosus.
    Carlsen AL; Schetter AJ; Nielsen CT; Lood C; Knudsen S; Voss A; Harris CC; Hellmark T; Segelmark M; Jacobsen S; Bengtsson AA; Heegaard NH
    Arthritis Rheum; 2013 May; 65(5):1324-34. PubMed ID: 23401079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
    Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
    Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
    Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
    Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
    Wu L; Han X; Jiang X; Ding H; Qi C; Yin Z; Xiao J; Xiong L; Guo Q; Ye Z; Qu B; Shen N
    Front Immunol; 2021; 12():747616. PubMed ID: 34745118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis.
    You G; Cao H; Yan L; He P; Wang Y; Liu B; Shao F
    Int Immunopharmacol; 2020 Nov; 88():106891. PubMed ID: 32853927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-203a-3p regulates TGF-β1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1.
    Fan Q; Jian Y
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32065213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of microRNA-199a-3p expression in CD4
    Wang H; Geng G; Zhang D; Han F; Ye S
    Clin Rheumatol; 2023 Jun; 42(6):1683-1694. PubMed ID: 36763225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of miR-21 and miR-155 in peripheral blood mononuclear cells as potential biomarkers for lupus nephritis.
    Khoshmirsafa M; Kianmehr N; Falak R; Mowla SJ; Seif F; Mirzaei B; Valizadeh M; Shekarabi M
    Int J Rheum Dis; 2019 Mar; 22(3):458-467. PubMed ID: 30398001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.